Predictive model using systemic inflammation markers to assess neoadjuvant chemotherapy efficacy in breast cancer
{{output}}
Background: Pathological complete response (pCR) is an important indicator for evaluating the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. The role of systemic inflammation markers in predicting pCR and the long-t... ...
